Breyer U, Petruch F, Gaertner H J, Pflug B
Arzneimittelforschung. 1976;26(6):1153.
Plasma levels of perazine, clozapine, amitriptyline and imipramine and of their demethylated metabolites can be measured in patients receiving therapeutic doses by UV reflectance photometry of thin-layer chromatograms of plasma extracts, Large inter-individual variations were observed in unselected psychiatric patients treated with comparable doses. An investigation into the relationship between plasma levels and therapeutc effect in acutely schizophrenic patients was carried out for perazine and clozapine. With perazine, a group of patients exhibiting an unsatisfactory response had a tendency to show lower plasma levels than a group with a good response; in some patients of the former group, increase of the dose with concomitant increase of the plasma level led to a satisfactory therapeutic effect. In patients treated with clozapine, such a relationship could not be demonstrated.
接受治疗剂量的患者,可通过血浆提取物薄层色谱图的紫外反射光度法测定奋乃静、氯氮平、阿米替林、丙咪嗪及其去甲基代谢物的血浆水平。在接受相当剂量治疗的未挑选的精神病患者中观察到个体间存在很大差异。对急性精神分裂症患者进行了奋乃静和氯氮平血浆水平与治疗效果之间关系的研究。对于奋乃静,一组反应不佳的患者血浆水平往往低于反应良好的一组;在前一组的一些患者中,增加剂量并伴随血浆水平升高导致了满意的治疗效果。在接受氯氮平治疗的患者中,未证实存在这种关系。